Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Payables (2017 - 2025)

Historic Payables for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $40.2 million.

  • Organogenesis Holdings' Payables rose 6778.19% to $40.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.2 million, marking a year-over-year increase of 6778.19%. This contributed to the annual value of $28.9 million for FY2024, which is 590.09% down from last year.
  • Organogenesis Holdings' Payables amounted to $40.2 million in Q3 2025, which was up 6778.19% from $29.7 million recorded in Q2 2025.
  • Organogenesis Holdings' Payables' 5-year high stood at $40.2 million during Q3 2025, with a 5-year trough of $23.2 million in Q1 2024.
  • Moreover, its 5-year median value for Payables was $28.9 million (2024), whereas its average is $29.4 million.
  • As far as peak fluctuations go, Organogenesis Holdings' Payables plummeted by 2942.66% in 2023, and later surged by 6778.19% in 2025.
  • Organogenesis Holdings' Payables (Quarter) stood at $29.3 million in 2021, then rose by 10.19% to $32.3 million in 2022, then decreased by 4.97% to $30.7 million in 2023, then dropped by 5.9% to $28.9 million in 2024, then soared by 39.11% to $40.2 million in 2025.
  • Its Payables stands at $40.2 million for Q3 2025, versus $29.7 million for Q2 2025 and $24.7 million for Q1 2025.